STING1 and neoplasm: Thus, it is plausible that, in the context of OSU13 treatment, STING acted not as the inducer of SASP, but rather a SASP modifier that established a secretome favorable to tumor growth inhibition, tumor surveillance by T cells, and antitumor immune response.